Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages jnumed.120.245803

出版商

Society of Nuclear Medicine

发表日期

2020-06-13

DOI

10.2967/jnumed.120.245803

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation